Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 115.50 112.00 119.00 115.50 115.50 115.50 48,681 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 166.8 7.1 -0.9 - 123

Cello Health Share Discussion Threads

Showing 726 to 747 of 1100 messages
Chat Pages: Latest  32  31  30  29  28  27  26  25  24  23  22  21  Older
DateSubjectAuthorDiscuss
20/3/2014
07:27
agreed, well done them, with economic cycle in their favour at the mo as well, me thinks this really IMO should be over a quid...i'm a long-term holder....
qs9
20/3/2014
07:13
Wow! Seriously impressive results! Well done Cello! The outlook comments are especially bullish; only a few months into the year and their confident of the 2014 results: Current Trading and Outlook Cello begins 2014 with a good level of secured forward bookings and has also seen encouraging levels of new business wins so far this year. The strong balance sheet position of the Group means the Board is able to further invest in the growth strategy and continue to build the Cello brand in the global marketplace. This is an exciting time for the Group and the focus of the Board is set on driving profitable growth from the high level marketing advisory platform that has successfully been established. We have two well managed, well structured and highly competitive brands in Cello Health and Cello Signal. These are only now starting to show their true potential. At this early stage of the year, the Board is confident that expectations for 2014 will be met.
sagarn
20/3/2014
07:12
Ok those IMO are pretty great results and debt nearly gone....broker target price I believe was around £1.20 after trading update....wonder whether any upgrades will be forthcoming now after full year??
qs9
19/3/2014
09:49
QS99: Yes indeed tomorrow. Considering the recent update, can't imagine they will be anything but superb based on... RE-CLOSE TRADING UPDATE - YEAR ENDED 31 DECEMBER 2013 Strong performance, ahead of consensus market expectations Cello, the insight and strategic marketing group, today publishes the following trading update for the year ended 31 December 2013. Highlights - Strong trading for the year, revenues and headline profit before tax ahead of consensus market expectations - Cello Health delivers double digit revenue growth and maintains 20% operating margin - Cello Consumer delivers double digit revenue growth and restores double digit operating margin - Very strong cash conversion, reducing net debt to below expected levels - Growth investments in healthcare ventures prove successful in first year - Good new business pipeline in Q4 2013 underpins solid start to 2014 - Group rebranding initiatives proceeding to plan
sagarn
19/3/2014
09:35
Results tomorrow i believe...
qs99
06/3/2014
16:44
Results should be good,market thinks so as well by the look of it
tom111
04/3/2014
10:58
Looking good...
qs99
28/2/2014
11:40
Yes an odd IMO 10% drop, given recent statements and material broker upgrade...buying opportunity perhaps?
qs99
27/2/2014
19:43
Results next month,should liven the share price up.i notice a lot of sellers today,strange because the results will be outstanding according to the trading statement
tom111
04/2/2014
20:20
Nice move upwards today....see earlier posts, obviously a few like the story and are stocking up
qs9
23/1/2014
10:08
From what I can see, upgraded target price by broker to £1.18... Dyor etc, but looks like market waking up to stage of cycle we are in and cellos prospects IMO...
qs99
22/1/2014
17:05
Nice end to day....tip sheets may pick this up next week....IMO...
qs99
22/1/2014
14:17
Thanks for that...with recovery gathering momentum, these sort of firms IMO may attract higher multiples as market anticipates faster growth and upgrades IMO.....lets see,...
qs99
22/1/2014
08:52
Net debt end H1 was £11.4m and now below £4m so they've had a bumper H2 for cash flow (tho some seasonality it would seem). Adjusted pbt was £3.5m in H1 so they've done in excess of £4.5m in H2. Very strong...tho numbers quite clouded with exceptionals very often at CLL. Current f/c for coming year is 7.41p so forward P/E c. 11.6 at 86p. So end 2014 should be (net!) debt free (assuming no acquisitions etc), growing, and a pretty modest P/E if meet/beat. CLL has traded on a much lower P/E over the years when much more debt/earnouts etc so not exactly a no-brainer but looks good to me here at this valuation, balance sheet situation etc. Mr Market will decide. I've added to the Eezymunny portfolio today http://uk.advfn.com/cmn/fbb/thread.php3?id=30375760&from=195
eezymunny
22/1/2014
08:42
Well, if you want a negative, then: "A single large, non-recurring contract from an existing client expanded rapidly in the second half of 2013, contributing to this particularly high level of profit growth. This particular contract will not recur."
wjccghcc
22/1/2014
08:40
That should read "not far" sorry!
qs99
22/1/2014
08:40
Debt far to being paid off, earnings on up, good margin, economic cycle turning, what's not to like IMO? Why isn't it on a p/e of 15+?
qs99
22/1/2014
08:01
Superb, positive trading update today. I searched, but couldn't find anything obviously negative. I'm sure I'll be corrected if I have that wrong though!
dashton42
22/1/2014
07:55
not a buy until one off contract is replaced
zipstuck
07/1/2014
20:27
Thanks Dashton, I missed the article.Good write up all being said, happy days for cello and I.
morph7
17/12/2013
20:34
From November's 'Company Refs', when price was 69p:- a/ Prospective PE ratio of 9.44 (based on three broker forecasts, all recommending 'buy'). b/ Positive cash flow per share of 5.15p. c/ Positive gearing of 13.3%. d/ Price to sales ratio of 0.40. e/ Net cash per share of 4.42p. f/ Net asset value per share of 79.9p. g/ Two directors buying recently. h/ Dividend yield of 3.45%.
welsheagle
28/11/2013
16:22
Yearly high. Here's TTY o hoping it stays above 70p.
morph7
Chat Pages: Latest  32  31  30  29  28  27  26  25  24  23  22  21  Older
ADVFN Advertorial
Your Recent History
LSE
CLL
Cello Heal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200607 10:54:24